Share this article
Share this article
LONDON, Feb. 17, 2021 /PRNewswire/ LYPHE Group, U.K. s leading medical cannabis provider, with more than 60% of the British patient market, and Canadian independent EU GMP manufacturer, Northern Green have entered into a supply partnership that will see a range of indoor grown flowers enter the market under the brand name of NOIDECS.
The flowers are now available in the private market and through NOIDECS inclusion on the formulary of Europe s largest patient real world data registry, Drug Science s Project Twenty21. Under the agreement, NOIDECS is also expanding the range into other International territories.
LYPHE Group imports Northern Green Canada into the U K market as supply to the medical cannabis brand, NOIDECS prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
This article by Corey Noles was originally published on Cannabis & Tech Today, and appears here with permission.
The UK is now the largest producer and exporter of legal cannabis in Europe, according to a new report.
The report, released by released ResearchandMarkets.com, is titled
The European market is expected to reach $37 billion by 2027 from $3.5 billion in 2019; it is anticipated to grow at a CAGR of 29.6% from 2020 to 2027.
The growth of the market in this region is attributed to the upgrading of regulations for medical cannabis and growth of the cannabis industry as well as an increase in microdosing. However, challenges related to cannabis hinder the market growth.
European Cannabis Market Report 2020-2027: UK has Emerged as the Largest Producer and Exporter of Legalized Cannabis
ResearchAndMarkets.com s offering. The Europe cannabis market is expected to reach US$ 36,997.1 million by 2027 from US$ 3,498.1 million in 2019; it is anticipated to grow at a CAGR of 29.6% from 2020 to 2027.
The growth of the market in this region is attributed to the upgrading of regulations for medical cannabis and growth of the cannabis industry. However, challenges related to cannabis hinder the market growth.
The European countries are experiencing transformation in the regulations for marketing cannabis and related products. The changes in the regulations have allowed the cultivation, processing, and trade of the cannabis-derived products across this region. In addition, the online distribution of CBD has received more attention, and companies are emerging at a faster rate.